Astrana Health Inc.

NASDAQ: ASTH · Real-Time Price · USD
29.34
-0.20 (-0.68%)
At close: Aug 15, 2025, 10:02 AM
-0.68%
Bid 29.3
Market Cap 1.46B
Revenue (ttm) 2.25B
Net Income (ttm) 35.01M
EPS (ttm) 0.52
PE Ratio (ttm) 56.42
Forward PE 11.99
Analyst Buy
Ask 29.4
Volume 37,416
Avg. Volume (20D) 339,261
Open 29.85
Previous Close 29.54
Day's Range 29.32 - 29.98
52-Week Range 21.20 - 63.20
Beta 0.85

About ASTH

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ASTH
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ASTH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Astrana Health has released their quartely earnings on Aug 7, 2025:
  • Revenue of $654.8M exceeds estimates by $17.78M, with 34.66% YoY growth.
  • EPS of 0.19 misses estimates by -0.24, with -52.50% YoY decline.
  • Next Earnings Release

    Astrana Health Inc. is scheduled to release its earnings on Nov 6, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    6 days ago
    +30.85%
    Astrana Health shares are trading higher after the... Unlock content with Pro Subscription
    1 week ago
    -1.6%
    Astrana Health shares are trading higher after the company reported better-than-expected Q2 sales results, issued Q3 sales guidance above estimates, and issued FY25 sales guidance above estimates.